Ogawa, A., Izumikawa, K., Tate, S., Isoyama, S., Mori, M., Fujiwara, K., Watanabe, S., Ohga, T., Jo, U., Taniyama, D., Kitajima, S., Tanaka, S., Onji, H., Kageyama, S.-I., Yamamoto, G., Saito, H., Morita, T. Y., Okada, M., Natsumeda, M., Nagahama, M., Kobayashi, J., Ohashi, A., Sasanuma, H., Higashiyama, S., Dan, S., Pommier, Y. and Murai, J. SLFN11-mediated ribosome biogenesis impairment induces TP53-independent apoptosis.
Mol. Cell, in press (2025) |
Utsumi, T., Mizuta, H., Seto, Y., Uchibori, K., Nishio, M., Okamoto, I. and Katayama, R. AXL-mediated drug resistance in ALK-rearranged NSCLC enhanced by GAS6 from macrophages and MMP11 positive fibroblasts.
Cancer Sci., in press (2025) |
Maruyama, K., Shimizu, Y., Nomura, Y., Oh-hara, T., Takahashi, Y., Nagayama, S., Fujita, N. and Katayama, R. Mechanisms of KRAS inhibitor resistance in KRAS-mutant colorectal cancer harboring Her2 amplification and aberrant KRAS localization.
npj Precis Oncol, in press (2025) |
Sasaki, N., Homme, M., Murayama, T., Osaki, T., Tenma, T., An, T., Takegami, Y., Tani, T., Gedeon, P. C., Kobayashi, Y., Cañadas, I., Barbie, D. A., Yao, R. and Kitajima, S. RNA sensing induced by chromosome missegregation augments anti-tumor immunity.
Mol. Cell, in press (2024) |
Fujimura, T., Furugaki, K., Mizuta, H., Muraoka, S., Nishio, M., Adachi, J., Uchibori, K., Miyauchi, E., Hayashi, H., Katayama, R. and Yoshiura, S. Targeting ErbB and tankyrase1/2 prevent the emergence of drug-tolerant persister cells in ALK-positive lung cancer.
NPJ Precis. Oncol., 264, in press (2024)
|
Okazaki, F., Yorozu, A., Sekiguchi, S., Niinuma, T., Maruyama, R., Kitajima, H., Yamamoto, E., Ishiguro, K., Toyota, M., Hatanaka, Y., Nishiyama, K., Ogi, K., Kai, M., Takano, K., Ichimiya, S., Miyazaki, A. and Suzuki, H. AEBP1 is a negative regulator of skeletal muscle cell differentiation in oral squamous cell carcinoma.
Sci. Rep., 14, 27425 (2024) |
Watanabe, K., Yamamoto, T., Fujita, T., Hino, S., Hino, Y., Yamazaki, K., Ohashi, Y., Sakuraba, S., Kono, H., Nakao, M., Ochiai, K., Dan, S. and Saitoh, N. Metabolically inducing defects in DNA repair sensitizes BRCA–wild-type cancer cells to replication stress.
Science signaling, 17, in press (2024)
|
Yamauchi, S., Sugiura, Y., Yamaguchi, J., Zhou, X., Takenaka, S., Odawara, T., Fukaya, S., Fujisawa, T., Naguro, I., Uchiyama, Y., Takahashi, A. and Ichijo, H.
Mitochondrial fatty acid oxidation drives senescence.
Sci. Adv., 10, eado5887 (2024) |
Otsuji, K., Takahashi, Y., Osako, T., Kobayashi, T., Takano, T., Saeki, S., Yang, L., Baba, S., Kumegawa, K., Suzuki, H., Noda, T., Takeuchi, K., Ohno, S., Ueno, T. and Maruyama, R. Serial single-cell RNA sequencing unveils drug resistance and metastatic traits in stage IV breast cancer.
NPJ Precis. Oncol., (2024) |
Wei, X., Uchibori, K., Kondo, N., Utsumi, T., Takemoto, A., Koike, S., Takagi, S., Yanagitani, N., Nishio, M. and Katayama, R. MIG6 loss increased RET inhibitor tolerant persister cells in RET-rearranged non-small cell lung cancer.
Cancer Lett., in press (2024) |
![ENGLISH](../common/images/hlink_english.gif"){kind=small}
